SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as its community grapples with mixed sentiments amidst ongoing price stagnation, despite some believing a potential merger involving Zero Hash and Mastercard, alongside progress on the Clarity Act, could be catalysts. Many holders are expressing frustration over consistent declines, while others are actively accumulating, pointing to Flexa's real-world utility with major merchants and recent patents as reasons for long-term optimism. The debate rages between those who see it as a foundational payment collateral token and those who fear it's a 'dead project' that continually disappoints.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing highly polarized sentiment, with many in the community expressing frustration over significant losses and year-end tax-loss selling contributing to downward pressure. Despite widespread discussions questioning its utility and sustained underperformance relative to other major cryptocurrencies, a dedicated segment of holders maintains long-term conviction, eagerly anticipating a future resurgence.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending with a massive volume surge and price rally following news of a strategic manufacturing partnership aimed at scaling production of its drug screening reader for future U.S. market entry. The community is intensely divided, with bulls pointing to the low float and the positive impact of a $10 million private placement on its balance sheet, while bears express significant concern over dilution, the company's reverse split history, and the offering's terms.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to massive trading volume and a significant price surge, sparking intense community discussion around its low-float SPAC nature. Traders are actively anticipating further upward movement and a potential squeeze, drawing parallels to other recently explosive micro-cap plays that have experienced rapid ascents.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

Alchemy Investments Acquisition Corp 1 (ALCY) is generating significant buzz as a low-float SPAC, with traders actively discussing its potential for a substantial price run. The community is drawing strong parallels to recent 'shell company rippers' like ESHA, anticipating a considerable upward movement fueled by limited circulating shares and growing speculative interest.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending due to its new integration with a Stripe-owned fiat anchor, which enables seamless, compliant bank-to-stablecoin transfers at a verified 11 million transactions per second. The community sees it as a potentially undervalued Layer 1 blockchain, poised to become essential financial infrastructure for institutions by offering high-speed, regulated settlement rails. This focus on enterprise-grade plumbing for global finance differentiates it from many other crypto projects.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing significant upward momentum as the FDA granted Priority Review for its AXS-05 in Alzheimer's disease agitation, with a PDUFA target date of April 30, and confirmed a clear path for its AXS-12 narcolepsy treatment. This major regulatory progress, alongside robust Auvelity sales growth and numerous analyst price target increases, has ignited strong bullish sentiment across the community. Many are celebrating long-term holdings and are optimistic about Axsome's potential to capitalize on substantial market opportunities in CNS disorders.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending with significant community anticipation for the start of a new yearly cycle, driving strong bullish sentiment for substantial long-term gains. Many investors are actively accumulating, citing historical patterns that suggest an imminent upward trajectory. The discussion is marked by strong convictions from bulls, despite ongoing skepticism from bears regarding its immediate outlook.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending amid intense community debate, primarily driven by widespread shareholder frustration with CEO Richard Paulson and the board, whom many accuse of continuous value destruction and mismanagement. Recent financing and a reverse stock split, while extending the cash runway, have amplified concerns about dilution and executive accountability. Despite this pervasive negative sentiment toward leadership, significant bullish options activity and anticipation for upcoming Phase 3 trial readouts in Myelofibrosis and Endometrial Cancer highlight an underlying belief in the company's scientific potential, contingent on a change in management.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending due to recent strategic moves, including pipeline expansion through acquisitions and manufacturing advancements for its lead anticoagulant candidate, Tecarfarin. The market is weighing the potential of these developments, including analyst-assigned price targets and FDA designations, against community concerns about cash burn, dilution, and the company's ability to fund pivotal Phase 3 trials. This creates a polarized discussion, highlighting the high-stakes nature of micro-cap biopharma investments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Notable Monday Option Activity: XP, CLF, VKTX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in XP Inc - Class A (Symbol: XP), where a total volume of 37,738 contracts has been...

Ex-Dividend Reminder: Fidelis Insurance Holdings, XP and VFC

Looking at the universe of stocks we cover at Dividend Channel, on 12/10/25, Fidelis Insurance Holdings Ltd (Symbol: FIHL), XP Inc - Class A (Symbol: XP), and VF Corp. (Symbol: VFC) will all trade...

Should Value Investors Buy XP (XP) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Does XP Inc.A (XP) Have the Potential to Rally 32.21% as Wall Street Analysts Expect?

The mean of analysts' price targets for XP Inc.A (XP) points to a 32.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

XP Inc.A (XP) Meets Q3 Earnings Estimates

XP Inc.A (XP) delivered earnings and revenue surprises of 0.00% and -0.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

XP Inc. Announces Cash Dividend, Treasury Shares Retirement and New Share Repurchase Program

XP Inc. (Nasdaq: XP), announced today that its board of directors has approved three capital allocation actions: (i) the declaration of a cash dividend, (ii) the retirement of treasury shares, and...

XP Inc. Reports Third Quarter 2025 Results

XP Inc. (NASDAQ: XP) (XP or the Company), a leading tech-enabled platform and a trusted pioneer in providing low-fee financial products and services in Brazil, reported today its financial results...

Are Investors Undervaluing XP (XP) Right Now?

XP Investor News: Rosen Law Firm Encourages XP Inc. Investors to Inquire About Securities Class Action Investigation XP

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of XP Inc. (NASDAQ: XP) resulting from allegations that XP may...

Exuberance is high on Wall Street, with most key indices closing in uncharted territory following the release of the consumer price inflation data for August that largely aligned with expectations.The final key data ahead of the Sept. 16-17 Federal Open Market Committee (FOMC) meeting has solidified the case for a rate cut, with investors now debating whether it will be a 25-basis-point (bps) reduction or a larger 50-bps cut.&nbsp;The S&amp;P 500 Index, the tech-heavy Nasdaq Composite, the Nasdaq 100, comprising 100 of the biggest non-financial tech companies, and the Dow Jones Industrial Average all closed at fresh highs.Amid the market’s record run, the following stocks saw increased volume in Thursday’s extended session:TechnipFMC Plc (FTI)After-hours move: +1.12%Trading volume: 23.07 millionShares of the French-American oilfield services company fell 1.44% in the regular session before rebounding in the after-hours. The volume spike&nbsp;occurred ahead of the company’s inclusion in the S&amp;P MidCap 400 Index,&nbsp;effective prior to the market opening on Friday.The stock has been on investors’ radar ever since it announced that Petrobras had awarded it two subsea contracts for flexible pipe for use in multiple basins. The company did not quantify the contract but said one of them is “substantial” ($250 million to $500 million) and another is significant ($50 million to $250 million).On Stocktwits, retail sentiment toward TechnipFMC stock improved to ‘bullish’ (55/100) by late Thursday from ‘neutral’ a day ago. The message volume on the stream stayed at ‘high’ levels.<a href="https://stocktwits.com/symbol/FTI">TechnipFMC stock</a> has gained nearly 40% this year.&nbsp;Nvidia Corp. (NVDA)After-hours move: +0.03%Trading volume: 5.21 millionNvidia traded ex-dividend on Thursday (Sept. 11), with traders buying the stock on or after the date not receiving the $0.01 per share dividend the company declared via its quarterly earnings release. Also, CEO Jesnsen Huang continued to offload his stake in the company as per a prearranged trading plan. On Thursday, the company disclosed in a Form 4 filing that Huang sold 225,000 Nvidia shares, valued at $39.3 million, in a series of transactions done between Sept. 9 and 11.&nbsp;Separately, DA&nbsp;Davidson analysts in a note released Thursday upgraded&nbsp;<a href="https://stocktwits.com/symbol/NVDA">Nvidia stock</a> to ‘Buy’ from ‘Neutral’ and increased the price target to $210 from $195, citing their optimistic artificial intelligence compute demand forecast.Retail continued to hold a pessimistic view of the stock, with the Stocktwits sentiment meter for it reading 41/100, suggesting a ‘bearish’ disposition. The message volume was also ‘low.’For the year-to-date period, Nvidia stock is up about 32%.Skechers USA, Inc. (SKX):&nbsp;After-hours move: +0.06%Trading volume: 5.14 million<a href="https://stocktwits.com/symbol/SKX">Skechers’ stock</a> will cease trading on the NYSE as it is being taken private by 3G Capital in a $9.4 billion deal. The stock elicited ‘bearish’ sentiment (43/100) from among Stocktwits users, with the sour mood accompanied by ‘normal’ message volume.XP Inc. (XP)After-hours move: +0.32%Trading volume: 4.32 millionCayman Islands-headquartered XP is a Brazilian financial services company.&nbsp; The stock’s volume surge came despite a lack of any company-specific catalysts.On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/XP">XP stock</a> remained ‘bearish’ (42/100), and the message volume was also ‘low.’ The stock is up about 60% this year.Warner Bros. Discovery, Inc. (WBD)After-hours move: +9.77%Trading volume: 3.78 millionWarner Bros. Discovery stock experienced a bumper gain (29%) on Thursday’s session and rose further in the after-hours after a Wall Street Journal report, citing people familiar with the matter,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/warner-bros-discovery-stock-jumps-to-over-3-year-high-extends-gains-after-hours/chw8OtkRdwI">said</a> the company may be pursued by David Ellison’s Paramount Skydance (PSKY).Retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/WBD">Warner Bros. Discovery stock&nbsp;</a>improved to an ‘extremely bullish’ level (95/100) by late Thursday from ‘neutral’ a day ago. The message volume also spiked to ‘extremely high’ levels.Warner Bros. Discovery stock has gained nearly 53% this year, with much of that attributable to Thursday’s surge.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-partner-super-micro-stock-pops-after-hours-here-s-why/chw8XPpRdwO">Nvidia Partner Super Micro Stock Pops After-Hours: Here’s Why</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on July 23, 2025, in New York City. 

TechnipFMC, Nvidia, Skechers USA, XP, Warner Bros. Discovery: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Index inclusion and deal speculation triggered some of the brisk moves seen in Thursday’s extended session after the major indices notched up new highs in regular trading. 

Equity

Index inclusion and deal speculation triggered some of the brisk moves seen in Thursday’s extended session after the major indices notched up new highs in regular trading. 



XP, Inc. engages in the operation of technology-driven financial services platform. The firm provides customers with two principal types of offerings, financial advisory services for retail clients in Brazil, high-net-worth clients, international clients and corporate and institutional clients, and an open financial product platform providing access to over 800 investment products including equity and fixed income securities, mutual and hedge funds, structured products, life insurance, pension plans, real-estate investment funds (REITs) and others from XP, its partners and competitors. he company was founded by Guilherme Dias Fernandes Benchimol in 2001 and is headquartered in Vila Olimpia, Brazil.

XP
XP Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest XP News

XPXP Inc - Ordinary Shares - Class A